<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27581459</article-id>
<article-id pub-id-type="pmc">5005725</article-id>
<article-id pub-id-type="publisher-id">1444-16</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.1444-16.2016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group>
<subject>Development/Plasticity/Repair</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jeffries</surname>
<given-names>Marisa A.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2486-0457</contrib-id>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Urbanek</surname>
<given-names>Kelly</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torres</surname>
<given-names>Lester</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wendell</surname>
<given-names>Stacy Gelhaus</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9083-6933</contrib-id>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rubio</surname>
<given-names>Maria E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fyffe-Maricich</surname>
<given-names>Sharyl L.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5843-2023</contrib-id>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Center for Neuroscience, </aff>
<aff id="aff2"><sup>2</sup>Department of Pediatrics, Division of Neurology, and </aff>
<aff id="aff3"><sup>3</sup>Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania 15224, and </aff>
<aff id="aff4"><sup>4</sup>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Sharyl L. Fyffe-Maricich,
<addr-line>University of Pittsburgh, One Children's Hospital Dr., 4401 Penn Ave., RRB Rm 3512, Pittsburgh, PA 15224.</addr-line><email>sharyl.fyffemaricich@chp.edu</email>.</corresp>
<fn fn-type="con">
<p>Author contributions: M.A.J., M.E.R., and S.L.F.-M. designed research; M.A.J., K.U., L.T., S.G.W., and S.L.F.-M. performed research; M.A.J., L.T., S.G.W., M.E.R., and S.L.F.-M. analyzed data; M.A.J. and S.L.F.-M. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>31</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>3</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>36</volume>
<issue>35</issue>
<fpage>9186</fpage>
<lpage>9200</lpage>
<history>
<date date-type="received">
<day>2</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>7</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2016 the authors 0270-6474/16/369186-15$15.00/0</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="zns03516009186.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Growing evidence shows that mechanisms controlling CNS plasticity extend beyond the synapse and that alterations in myelin can modify conduction velocity, leading to changes in neural circuitry. Although it is widely accepted that newly generated oligodendrocytes (OLs) produce myelin in the adult CNS, the contribution of preexisting OLs to functional myelin remodeling is not known. Here, we show that sustained activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in preexisting OLs of adult mice is sufficient to drive increased myelin thickness, faster conduction speeds, and enhanced hippocampal-dependent emotional learning. Although preexisting OLs do not normally contribute to remyelination, we show that sustained activation of ERK1/2 renders them able to do so. These data suggest that strategies designed to push mature OLs to reinitiate myelination may be beneficial both for enhancing remyelination in demyelinating diseases and for increasing neural plasticity in the adult CNS.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Myelin is a crucial regulator of CNS plasticity, function, and repair. Although it is generally accepted that new myelin production in the adult CNS is initiated by newly generated oligodendrocytes (OLs), great interest remains in additionally driving mature preexisting OLs to make myelin. The ability to induce myelination by the larger population of preexisting OLs carries the potential for enhanced remyelination in demyelinating diseases and increased neural plasticity in the adult CNS. Here, we show that sustained activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathway is sufficient to drive mature OLs in the adult mouse CNS to reinitiate myelination, leading to new myelin wraps and functional changes.</p>
</abstract>
<kwd-group>
<kwd>ERK MAP kinase</kwd>
<kwd>intracellular signaling</kwd>
<kwd>myelin</kwd>
<kwd>myelin plasticity</kwd>
<kwd>oligodendrocyte</kwd>
<kwd>remyelination</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>twij</meta-name>
<meta-value>true</meta-value>
</custom-meta>
<custom-meta>
<meta-name>special-property</meta-name>
<meta-value>cellular</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>